Immunohistochemistry for iPLA2β and PAF revealed increased expression in higher grade tumor regions when compared to low‐grade tumors (Figs. 5 and 7) suggesting that this specific pathway may play a role in tumor progression in the bladder. The gene discussed is PCLAF; the disease is neoplasm.